PlainRecalls
FDA Drug Critical Class I Terminated

Benzonatate capsules, 100mg, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 67877-0573-05

Reported: June 1, 2022 Initiated: January 15, 2021 #D-1124-2022

Product Description

Benzonatate capsules, 100mg, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 67877-0573-05

Reason for Recall

Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.

Details

Units Affected
10 bottles
Distribution
1 physician in Alpharetta, GA
Location
Albuquerque, NM

Frequently Asked Questions

What product was recalled?
Benzonatate capsules, 100mg, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 67877-0573-05. Recalled by Calvin Scott & Company, Inc.. Units affected: 10 bottles.
Why was this product recalled?
Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 1, 2022. Severity: Critical. Recall number: D-1124-2022.